Works in Cancer Chemotherapy & Pharmacology, 2019, Vol 84, Issue 6

Results: 23

Prevalence of the DPYD variant (Y186C) in Brazilian individuals of African ancestry.

Published in:

2019

By:

Cunha-Junior, Geraldo Felício;
Bastos-Rodrigues, Luciana;
Azevedo, Pedro G.;
Bicalho, Maria Aparecida;
Magno, Luiz Alexandre V.;
De Marco, Luiz;
Coelho, Luiz Gonzaga

Publication type:

journal article

Alternative dosing regimens for atezolizumab: right dose, wrong frequency.

Published in:

2019

By:

Goldstein, Daniel A.;
Ratain, Mark J.

Publication type:

Editorial

Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1.

Published in:

2019

By:

Turan, Caner;
Kantar, Mehmet;
Aktan, Çağdaş;
Kosova, Buket;
Orman, Mehmet;
Bilgen, Cem;
Kirazlı, Tayfun

Publication type:

journal article

A phase I delayed-start, randomized and pharmacodynamic study of metformin and chemotherapy in patients with solid tumors.

Published in:

2019

By:

Saif, Mohammad Wasif;
Rajagopal, Shrikar;
Caplain, Jennifer;
Grimm, Elizabeth;
Serebrennikova, Oksana;
Das, Madhumita;
Tsichlis, Philip N.;
Martell, Robert

Publication type:

journal article

Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients.

Published in:

2019

By:

Kawakatsu, Sonoko;
Nikanjam, Mina;
Lin, Mark;
Le, Sonny;
Saunders, Ila;
Kuo, Dennis John;
Capparelli, Edmund V.

Publication type:

journal article

NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells.

Published in:

2019

By:

Liu, Ling;
Chen, Jingjing;
Cao, Mengyao;
Wang, Jiangang;
Wang, Shuying

Publication type:

journal article

Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.

Published in:

2019

By:

Rivera, Fernando;
Romero, C.;
Jimenez-Fonseca, P.;
Izquierdo-Manuel, M.;
Salud, A.;
Martínez, E.;
Jorge, M.;
Arrazubi, V.;
Méndez, J. C.;
García-Alfonso, P.;
Reboredo, M.;
Barriuso, J.;
Muñoz-Unceta, N.;
Jimeno, R.;
López, C.

Publication type:

corrected article

Metformin plus first-line chemotherapy versus chemotherapy alone in the treatment of epithelial ovarian cancer: a prospective open-label pilot trial.

Published in:

2019

By:

Zheng, Ya;
Zhu, Jie;
Zhang, Haiyan;
Liu, Yanmei;
Sun, Hong

Publication type:

journal article

Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer.

Published in:

2019

By:

Sun, Yuliang;
Lin, Xiaoqian;
Aske, Jennifer Carlson;
Ye, Ping;
Williams, Casey;
Abramovitz, Mark;
Leyland-Jones, Brian R.

Publication type:

journal article

Combined thermo-chemotherapy of cancer using 1 MHz ultrasound waves and a cisplatin-loaded sonosensitizing nanoplatform: an in vivo study.

Published in:

2019

By:

Irajirad, Rasoul;
Ahmadi, Amirhossein;
Najafabad, Bahareh Khalili;
Abed, Ziaeddin;
Sheervalilou, Roghayeh;
Khoei, Samideh;
Shiran, M. Bagher;
Ghaznavi, Habib;
Shakeri-Zadeh, Ali

Publication type:

journal article

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.

Published in:

2019

By:

Appleman, Leonard J.;
Beumer, Jan H.;
Jiang, Yixing;
Lin, Yan;
Ding, Fei;
Puhalla, Shannon;
Swartz, Leigh;
Owonikoko, Taofeek K.;
Donald Harvey, R.;
Stoller, Ronald;
Petro, Daniel P.;
Tawbi, Hussein A.;
Argiris, Athanassios;
Strychor, Sandra;
Pouquet, Marie;
Kiesel, Brian;
Chen, Alice P.;
Gandara, David;
Belani, Chandra P.;
Chu, Edward

Publication type:

journal article

ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer.

Published in:

2019

By:

Uemura, Takehiro;
Oguri, Tetsuya;
Maeno, Ken;
Sone, Kazuki;
Takeuchi, Akira;
Fukuda, Satoshi;
Kunii, Eiji;
Takakuwa, Osamu;
Kanemitsu, Yoshihiro;
Ohkubo, Hirotsugu;
Takemura, Masaya;
Ito, Yutaka;
Niimi, Akio

Publication type:

journal article

BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.

Published in:

2019

By:

Yang, Wei;
Zhao, Sihui;
Wu, Bian;
Xu, Jianbiao;
Wu, Zaozao;
Guo, Jianhui;
Zeng, Rong

Publication type:

journal article

JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer.

Published in:

2019

By:

Yoshino, Takayuki;
Kotaka, Masahito;
Shinozaki, Katsunori;
Touyama, Tetsuo;
Manaka, Dai;
Matsui, Takanori;
Ishigure, Kiyoshi;
Hasegawa, Junichi;
Inoue, Keiji;
Munemoto, Yoshinori;
Takagane, Akinori;
Ishikawa, Hiroshi;
Ishida, Hideyuki;
Ogata, Yutaka;
Oba, Koji;
Goto, Koichi;
Sakamoto, Junichi;
Maehara, Yoshihiko;
Ohtsu, Atsushi

Publication type:

journal article

Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.

Published in:

2019

By:

Cao, Yanshuo;
Chang, Qing;
Zhang, Wenjiang;
Ornatsky, Olga;
Hedley, David;
Chen, Eric X.

Publication type:

journal article

Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial.

Published in:

2019

By:

Luu, Thehang;
Frankel, Paul;
Beumer, Jan H.;
Lim, Dean;
Cristea, Mihaela;
Appleman, Leonard J.;
Lenz, Heinz J.;
Gandara, David R.;
Kiesel, Brian F.;
Piekarz, Richard L.;
Newman, Edward M.

Publication type:

journal article

Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting.

Published in:

2019

By:

Morrissey, Kari M.;
Marchand, Mathilde;
Patel, Hina;
Zhang, Rong;
Wu, Benjamin;
Phyllis Chan, H.;
Mecke, Almut;
Girish, Sandhya;
Jin, Jin Y.;
Winter, Helen R.;
Bruno, René

Publication type:

journal article

Enhancing intratumoral biodistribution and antitumor activity of nab-paclitaxel through combination with a vascular disrupting agent, combretastatin A-4-phosphate.

Published in:

2019

By:

Gao, Meng;
Zhang, Dongjian;
Yao, Nan;
Jin, Qiaomei;
Jiang, Cuihua;
Zhang, Jian;
Wang, Feng

Publication type:

journal article

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.

Published in:

2019

By:

Lubberman, Floor J. E.;
Benoist, Guillemette E.;
Gerritsen, Winald;
Burger, David M.;
Mehra, Niven;
Hamberg, Paul;
van Oort, Inge;
van Erp, Nielka P.

Publication type:

journal article

A reliable method to determine which candidate chemotherapeutic drugs effectively inhibit tumor growth in patient-derived xenografts (PDX) in single mouse trials.

Published in:

2019

By:

Gordon, Derek;
Axelrod, David E.

Publication type:

journal article

Dihydropyrimidine dehydrogenase in the metabolism of the anticancer drugs.

Published in:

2019

By:

Sharma, Vinay;
Gupta, Sonu Kumar;
Verma, Malkhey

Publication type:

journal article

Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy.

Published in:

2019

By:

Crucitta, Stefania;
Restante, Giuliana;
Del Re, Marzia;
Bertolini, Ilaria;
Bona, Eleonora;
Rofi, Eleonora;
Fontanelli, Lorenzo;
Gianfilippo, Giulia;
Fogli, Stefano;
Stasi, Irene;
Ghilli, Matteo;
Fontana, Andrea;
Danesi, Romano

Publication type:

journal article

Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.

Published in:

2019

By:

Zhang, Yanshan;
Chen, Weizuo;
Wang, Huijuan;
Pan, Tingting;
Zhang, Yinguo;
Li, Chao

Publication type:

journal article